Applied Biologics' XWRAP Delivers Significant Healing Boost for Diabetic Foot Ulcers
Applied Biologics has announced exciting new data for its XWRAP® treatment, showing it significantly improves the healing of stubborn diabetic foot ulcers. Updated results from the 222-patient CAMPX clinical trial reveal that patients using XWRAP along with standard care achieved much higher rates of complete wound closure, offering a real glimmer of hope for a condition that often leads to severe complications. These positive findings are now officially accepted for presentation at the important Symposium on Advanced Wound Care (SAWC) Fall 2026.
















